The well of novel antidepressants: running dry
- PMID: 20569647
- PMCID: PMC2895150
- DOI: 10.1503/jpn.100098
The well of novel antidepressants: running dry
Comment in
-
Possible directions for the discovery of new antidepressant treatments.J Psychiatry Neurosci. 2011 Jan;36(1):3-5. doi: 10.1503/jpn.100169. J Psychiatry Neurosci. 2011. PMID: 21167108 Free PMC article. No abstract available.
References
-
- Kennedy SH. Agomelatine: efficacy at each phase of antidepressant treatment. CNS Drugs. 2009;23(Suppl 2):41–7. - PubMed
-
- Joubert AF, du Plessis AD, Farles D, et al. High placebo response rate versus clinical impression with the new antidepressant duloxetine. Biol Psychiatry. 1997;42(Suppl 1):229S.
-
- Nemeroff CB, Schatzberg AF, Goldstein DJ, et al. Duloxetine for the treatment of major depressive disorder. Psychopharmacol Bull. 2002;36:106–32. - PubMed
-
- Sánchez C, B⊘ges⊘ KP, Ebert B, et al. Escitalopram versus citalopram: the surprising role of the R-enantiomer. Psychopharmacology (Berl) 2004;174:163–76. - PubMed
-
- Lobello KW, Preskorn SH, Guico-Pabia CJ, et al. Cytochrome P450 2D6 phenotype predicts antidepressant efficacy of venlafaxine: a secondary analysis of 4 studies in major depressive disorder. J Clin Psychiatry. 2010 Apr 6; [Epub ahead of print] - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical